Mark Rogers

Mark Rogers is the Co-Founder & CEO at BioXplor. He has over 15 years of experience in Emerging Biotech Business Development, Cell & Gene Therapy Research & Protein-Protein Interaction Screening. Mark is previously an Associate Director of Emerging Biotech at Merck KGaA and Cofounder of Curogenix.

Mark holds an MSc in Molecular Biotechnology.